Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

AI models need more data about biology, and OpenAI is paying to create it

15 September 2026 · By · Wire by Fusion42

Published

15 September 2026

Topic

opportunities

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at technologyreview.com →

◆ Verified

Fusion42 · 15 September 2026 · Fusion42 review

The OpenAI Foundation is funding efforts to create high-quality biological and medical datasets, including bidding for data from failed biotech companies, to overcome data scarcity in training AI models for health breakthroughs.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You can now tap into previously locked biotech data from bankrupt companies to train AI in drug development. The knockout move is to partner quickly with groups like 1Day Sooner that are pioneering access to these new datasets.

◆ Coverage

1 source · 15 Sep 2026

◆ Related on Wire

◆ Topics

Healthaibiomedical-dataopenai-foundationhealthcare-aibiotech-bankruptcy